The effects of pre-operative menopausal status and hormone replacement therapy (HRT) on sexuality and quality of life after risk-reducing salpingo-oophorectomy

Maturitas

Volumn 85, Issue , 2016, Pages 42-48

  Tucker, Paige E ^a,b   Bulsara, Max K ^b   Salfinger, Stuart G ^a   Tan, Jason Jit Sun ^a   Green, Helena ^c   Cohen, Paul A ^a,b  

^a ST JOHN OF GOD HOSPITAL   (Australia)

^b UNIVERSITY OF NOTRE DAME   (Australia)

^c Women Centre   (Australia)

Author keywords

BRCA1 2; Female sexual dysfunction; Hormone replacement therapy; Menopause; Risk reducing salpingo oophorectomy; Serum androgen levels

Indexed keywords

ANDROGEN; ESTROGEN; TESTOSTERONE;

ADULT; ARTICLE; BODY IMAGE; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DISTRESS SYNDROME; DYSPAREUNIA; EMOTION; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENOPAUSE; MENTAL STRESS; OUTCOME ASSESSMENT; PREOPERATIVE EVALUATION; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RISK REDUCTION; SALPINGOOOPHORECTOMY; SEXUAL AROUSAL; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SEXUALITY; TESTOSTERONE BLOOD LEVEL; ADVERSE EFFECTS; AGED; BLOOD; HUMAN RELATION; MIDDLE AGED; OVARIAN NEOPLASMS; OVARIECTOMY; POSTMENOPAUSE; PREMENOPAUSE; PREOPERATIVE PERIOD; PROPHYLACTIC SURGICAL PROCEDURE; PSYCHOLOGY; QUESTIONNAIRE; SALPINGECTOMY; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

ADULT; AGED; BODY IMAGE; CROSS-SECTIONAL STUDIES; DYSPAREUNIA; EMOTIONS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; INTERPERSONAL RELATIONS; MENOPAUSE; MIDDLE AGED; OVARIAN NEOPLASMS; OVARIECTOMY; POSTMENOPAUSE; PREMENOPAUSE; PREOPERATIVE PERIOD; PROPHYLACTIC SURGICAL PROCEDURES; QUALITY OF LIFE; SALPINGECTOMY; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SEXUALITY; STRESS, PSYCHOLOGICAL; SURVEYS AND QUESTIONNAIRES; TESTOSTERONE;

EID: 84959518142     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2015.12.004     Document Type: Article

References (30)

1. United States Cancer Statistics 1999-2011 Incidence and Mortality Web-based Report. Atlanta, USA, U.S. Cancer Statistics Working Group, (2014).
2. L.P. Shulman Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome Obstet. Gynecol. Clin. N. Am 37 2010 109 133 Table of Contents
3. K. Kerlikowske, J.S. Brown, and D.G. Grady Should women with familial ovarian cancer undergo prophylactic oophorectomy? Obstet. Gynecol. 80 1992 700 707
4. Genetic/Familial High Risk Assessment Breast and Ovarian, NCCN Clinical Practice Guidelines, 2 ed. National Comprehensive Cancer Network Inc. (2015).
5. C.Y. Fang, C. Cherry, K. Devarajan, T. Li, J. Malick, and M.B. Daly A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer Gynecol. Oncol. 112 2009 594 600
6. A. Finch, K.A. Metcalfe, J.K. Chiang, L. Elit, J. McLaughlin, C. Springate, and et al. The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation Gynecol. Oncol. 121 2011 163 168
7. J.B. Madalinska, J. Hollenstein, E. Bleiker, M. van Beurden, H.B. Valdimarsdottir, L.F. Massuger, and et al. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer J. Clin. Oncol. 23 2005 6890 6898
8. J.B. Madalinska, M. van Beurden, E.M. Bleiker, H.B. Valdimarsdottir, J. Hollenstein, L.F. Massuger, and et al. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy J. Clin. Oncol. 24 2006 3576 3582
9. M. Robson, M. Hensley, R. Barakat, C. Brown, D. Chi, E. Poynor, and et al. Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy Gynecol. Oncol. 89 2003 281 287
10. J.S. Chapman, C.B. Powell, J. McLennan, B. Crawford, J. Mak, N. Stewart, and et al. Surveillance of survivors: follow-up after risk-reducing salpingo-oophorectomy in BRCA 1/2 mutation carriers Gynecol. Oncol. 122 2011 339 343
11. J. Kotsopoulos, A.L. Shafrir, M. Rice, S.E. Hankinson, A.H. Eliassen, S.S. Tworoger, and et al. The relationship between bilateral oophorectomy and plasma hormone levels in postmenopausal women Horm. Cancer 6 2015 54 63
12. S.R. Davis, M.J. van der Mooren, R.H. van Lunsen, P. Lopes, C. Ribot, M. Rees, and et al. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial Menopause 13 2006 387 396
13. R. Rosen, C. Brown, J. Heiman, S. Leiblum, C. Meston, R. Shabsigh, and et al. The Female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function J. Sex Marital Ther. 26 2000 191 208
14. K. Thirlaway, L. Fallowfield, and J. Cuzick The sexual activity questionnaire: a measure of women's sexual functioning Qual. Life Res. 5 1996 81 90
15. L. Derogatis, A. Clayton, D. Lewis-D'Agostino, G. Wunderlich, and Y. Fu Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder J. Sex. Med. 5 2008 357 364
16. S. Hendrick A generic measure of relationship satisfaction J. Marriage Fam. 50 1988 93 98
17. M. Wiederman Women's body image self-consciousness during physical intimacy with a partner J. Sex Res. 37 2000 60 68
18. J.R. Hilditch, J. Lewis, A. Peter, B. van Maris, A. Ross, E. Franssen, and et al. A menopause-specific quality of life questionnaire: development and psychometric properties Maturitas 61 2008 107 121
19. J. Ware, and C. Sherbourne The MOS 36-item short-form health survey (SF-36) Med. Care 30 1992 473 483
20. M. Horowitz, N. Wilner, and M. Alvarez Impact of event scale: a measure of subjective stress Psychosom. Med. 41 1979 209 218
21. H.F.L. Meyer-Bahlburg, and C. Dolezal The female sexual function index: a methodological critique and suggestions for improvement J. Sex Marital Ther. 33 2007 217 224
22. M. Wiegel, C. Meston, and R. Rosen The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores J. Sex Marital Ther. 31 2005 1 20
23. E.P. Gerstenberger, R.C. Rosen, J.V. Brewer, C.M. Meston, L.A. Brotto, M. Wiegel, and et al. Sexual desire and the female sexual function index (FSFI): a sexual desire cutpoint for clinical interpretation of the FSFI in women with and without hypoactive sexual desire disorder J. Sex. Med. 7 2010 3096 3103
24. T. Lorenz, B. McGregor, and E. Swisher Relationship satisfaction predicts sexual activity following risk-reducing salpingo-oophorectomy J. Psychosom. Obstet. Gynaecol. 35 2014 62 68
25. C. Pezaro, P. James, J. McKinley, M. Shanahan, M.A. Young, and G. Mitchell The consequences of risk reducing salpingo-oophorectomy: the case for a coordinated approach to long-term follow up post surgical menopause Fam. Cancer 11 2012 403 410
26. A. Graziottin, and R. Basson Sexual dysfunction in women with premature menopause Menopause 11 2004 766 777
27. S.R. Davis, S.L. Davison, S. Donath, and R.J. Bell Circulating androgen levels and self-reported sexual function in women JAMA 294 2005 91 96
28. J.F.J. Randolph Jr., H. Zheng, N.E. Avis, G.A. Greendale, and S.D. Harlow Masturbation frequency and sexual function domains are associated with serum reproductive hormone levels across the menopausal transition J. Clin. Endocrinol. Metab. 100 2015 258 266
29. S. Wahlin-Jacobsen, A.T. Pedersen, E. Kristensen, N.C. Laessoe, M. Lundqvist, A.S. Cohen, and et al. Is there a correlation between androgens and sexual desire in women? J. Sex. Med. 12 2015 358 373
30. J. Nathorst-Böös, B. von Schoultz, and K. Carlström Elective ovarian removal and estrogen replacement therapy- effects on sexual life, psychological well-being and androgen status J. Psychosom. Obstet. Gynaecol. 14 1993 283 293